The facade of Moderna, Inc. headquarters is seen, Tuesday, Dec. 15, 2020, in Cambridge. THE CANADIAN PRESS/AP/Elise Amendola
Moderna is applying to Health Canada today for its COVID-19 vaccine to be approved for use in teenagers.
The Massachusetts-based company says a trial of 2,500 youth aged 12 to 17 in the United States indicated the vaccine was 93 per cent to 100 per cent effective against COVID-19.
Moderna is the second vaccine maker to apply for approval for youth; the Pfizer-BioNTech vaccine was authorized for kids as young as 16 in December and for youth 12 to 15 years old in May.
Both companies continue to test their vaccines on children as young as six months with hopes to apply for authorization by the fall.
Moderna has also filed for authorization to use its vaccine under emergency use regulations in the U.S and Canada.